Table 2. Inclusion criteria for hysteroscopic treatment in high-risk women with EC.

EC G1
No evidence of metastatic disease
No evidence of suspicious adnexal mass
Absence of lymphadenopathy
No history of HNPCC/Lynch II syndrome
No contraindication to medical treatment
Absence of LVSI at post-operative histology
No evidence of myometrial invasion (more than 3 mm) at post-operative histology

EC, endometrial cancer; G1, grade 1; HNPCC, hereditary non-polyposis colorectal cancer; LVSI, lymph-vascular space invasion.